Lifibrol
Product Specifications
UNSPSC Description
Lifibrol is a potent and oral activity hypolipidemic agent. Lifibrol decreases the plasma total cholesterol. Lifibrol has the potential for the research of hypercholesterolemia[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/lifibrol.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C(C=C1)OCC(CCC2=CC=C(C=C2)C(C)(C)C)O)O
Molecular Weight
342.43
References & Citations
[1]Locker PK, et al. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group. Clin Pharmacol Ther. 1995 Jan;57(1):73-88. |[2]Bell FP, et al. Action of the new hypolipidemic agent lifibrol (K12.148) on lipid homeostasis in normal rats: plasma lipids, hepatic sterologenesis, and the fate of injected [14C]acetate. Lipids. 1993 Dec;28(12):1079-85.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-124560/Lifibrol-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-124560/
Clinical Information
Phase 3
CAS Number
96609-16-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
